XML 99 R81.htm IDEA: XBRL DOCUMENT v3.7.0.1
Business Segments (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2015
Segment Reporting Information [Line Items]      
Net sales $ 764,281 $ 751,526 $ 748,591
Depreciation and amortization 26,001 23,452 21,604
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 80,543 76,761 78,763
Interest expense, net 14,906 16,592 14,305
Depreciation and amortization 26,001 23,452 21,604
Acquisition-related cost of goods sold   2,566  
Acquisition-related accrued compensation 1,680 1,680 747
Acquisition-related other, net (972)    
Pension settlement cost 1,702
Foreign currency (gains) losses, net (113) (7,609) (5,400)
Loss on extinguishment of debt 2,598    
Identifiable assets 623,397 607,835  
Operating Segments      
Segment Reporting Information [Line Items]      
Net sales 764,281 751,526 748,591
Depreciation and amortization 23,403 20,423 18,475
Adjusted EBITDA - Total segments 149,744 143,383 137,334
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 80,543 76,761 78,763
Interest expense, net 14,906 16,592 14,305
Depreciation and amortization 23,403 20,423 18,475
Acquisition-related cost of goods sold   2,566  
Acquisition-related accrued compensation 1,680 1,680 747
Acquisition-related transaction costs 1,274 618
Acquisition-related other, net (972)
Pension settlement cost 1,702
Gain on insurance claim (7,500)    
Foreign currency (gains) losses, net (113) (7,609) (5,400)
Loss on extinguishment of debt 2,598
Adjusted EBITDA - Total segments 149,744 143,383 137,334
Identifiable assets 521,386 524,247  
Operating Segments | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 497,745 486,140 470,800
Depreciation and amortization 20,132 17,149 15,430
Adjusted EBITDA - Total segments 130,261 127,442 120,259
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 20,132 17,149 15,430
Adjusted EBITDA - Total segments 130,261 127,442 120,259
Identifiable assets 442,521 444,751  
Operating Segments | Mineral Nutrition      
Segment Reporting Information [Line Items]      
Net sales 218,298 216,685 227,102
Depreciation and amortization 2,332 2,467 2,468
Adjusted EBITDA - Total segments 17,426 14,971 14,429
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 2,332 2,467 2,468
Adjusted EBITDA - Total segments 17,426 14,971 14,429
Identifiable assets 55,184 57,939  
Operating Segments | Performance Products      
Segment Reporting Information [Line Items]      
Net sales 48,238 48,701 50,689
Depreciation and amortization 939 807 577
Adjusted EBITDA - Total segments 2,057 970 2,646
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 939 807 577
Adjusted EBITDA - Total segments 2,057 970 2,646
Identifiable assets 23,681 21,557  
Operating Segments | MFAs and other | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 321,430 339,916 335,735
Operating Segments | Nutritional Specialties | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 111,282 94,084 81,702
Operating Segments | Vaccines | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 65,033 52,140 53,363
Corporate      
Segment Reporting Information [Line Items]      
Depreciation and amortization 2,598 3,029 3,129
Adjusted EBITDA - Total segments 29,625 29,323 27,315
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 2,598 3,029 3,129
Adjusted EBITDA - Total segments 29,625 29,323 $ 27,315
Identifiable assets $ 102,011 $ 83,588